Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

US Consumer Health Industry In 2023: FDA Decision On Lawful Use Of Hemp Top Of Mind

Jan 26 2023

• By Malcolm Spicer

• Source: Shutterstock

Related Content

US Consumer Health Industry In 2023: With Supply Chain Concerns Constant, Challenges Loom Larger

Jan 23 2023

US Consumer Health Industry In 2023: Monograph Results, Switch Hopes On OTC Drug Sector Radar

Jan 23 2023

On Emergent OTC Naloxone Switch, Tight Timeline For FDA Decision Following Advisory Committee

Jan 06 2023

Will ACNU Proposal’s Dual Rx/OTC Component Simultaneously Help And Hinder Switches?

Dec 01 2022

FDA's Initial IND Warnings For CBD Supplements Could Ignite Regulatory Test

Feb 16 2016

US Bill For CBD Supplement Path Draws Mixed Industry Response

Sep 12 2020

Additional Topics

International United States US States Dietary Supplements Cannabidiol CBD FDA Advertising, Marketing & Sales Business Strategies Commercial Compliance Consumer Ingredients Legislation Manufacturing Policy Politics Regulation Supply Chain

More from Cannabis/CBD

More from Ingredients & Safety

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window